Literature DB >> 35361029

Asymmetric effects of fine particulate matter and stringency policy on COVID-19 intensity.

Asif Razzaq1, Yiniu Cui2, Muhammad Irfan3,4,5, Apichit Maneengam6, Ángel Acevedo-Duque7.   

Abstract

This study aims to examine the influence of environmental performance (PM2.5) on COVID-19 intensity . For this purpose, we employ the newly introduced Hidden Panel Cointegration test and Nonlinear Panel Autoregressive Distributed Lag model. Results indicate the asymmetric linkages between PM2.5 and COVID-19 intensity, as the positive shock in PM2.5 raises the COVID-19 intensity by 21%, whereas the negative shock in PM2.5 decreases COVID-19 intensity by 12% in long-run. On the contrary, the positive shock in stringency measures decreases COVID-19 intensity by 42.8%, while the negative shock in stringency policy increases COVID-19 intensity by 66.7%. These findings imply that higher pollution increases the COVID-19 severity while higher stringency measures slow down people's movement and reduce COVID-19 intensity. However, a sudden negative shock in lockdown increases people's interaction, leading to a higher spread of the virus. These results suggest that governments should adopt stringent action plans to contain the transmissibility of COVID-19.

Entities:  

Keywords:  Air pollution; COVID-19 pandemic; PM2.5; asymmetric effects; climate change; non-Linear panel ARDL

Year:  2022        PMID: 35361029     DOI: 10.1080/09603123.2022.2059452

Source DB:  PubMed          Journal:  Int J Environ Health Res        ISSN: 0960-3123            Impact factor:   3.411


  2 in total

1.  Improving Public Health and Governance in COVID-19 Response: A Strategic Public Procurement Perspective.

Authors:  Ran Yan; Fuguo Cao
Journal:  Front Public Health       Date:  2022-05-30

2.  Assessing the nexus between fiscal policy, COVID-19, and economic growth.

Authors:  Tao Wang; Ke Gao; Chen Wen; Yuanzhi Xiao; Yan Bingzheng
Journal:  Environ Sci Pollut Res Int       Date:  2022-04-29       Impact factor: 5.190

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.